![]() |
市场调查报告书
商品编码
1954620
压力/接触式安全采血针市场规模、占有率、成长及全球产业分析:依类型、应用和地区划分的洞察与预测(2026-2034 年)Pressure/Contact-activated Safety Lancet Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球压力/接触式安全采血针市场规模为 4.5623 亿美元,预计 2026 年将成长至 5.0267 亿美元,到 2034 年将达到 11.6418 亿美元。这意味着在预测期内,复合年增长率 (CAGR) 为 11.07%。北美地区在 2025 年将以 42.37% 的市场占有率(相当于 1.9332 亿美元)引领市场,这主要得益于对先进设备的强劲需求以及针对慢性病监测产品的高额报销政策。
压力/接触式安全采血针是一次性使用的毛细血管采血装置,用于糖尿病管理和诊断。它们具有自动收缩功能,只需对指尖施加轻微压力即可启动。其易用性、减少疼痛和出血量少是推动其在医院、诊所和家庭医疗保健机构广泛应用的主要因素。
市场动态
驱动因素
全球糖尿病患者人数的不断增加是推动市场发展的主要因素。频繁的血糖监测对于有效管理糖尿病至关重要,这也推动了对安全采血针的需求。压力式采血针可提供稳定的穿刺深度,降低针刺伤风险,并方便在家中进行自我监测。根据国际糖尿病联盟(2025年7月)的数据,2024年全球有5.89亿成年糖尿病患者,预计到2050年这一数字将达到8.53亿。这凸显了对采血针的持续需求。
人们对安全糖尿病照护意识的提高以及微创技术的普及,进一步推动了医院、诊所和家庭护理领域的市场成长。
市场限制因子
市场面临依钮式采血针的竞争,这类采血针能够提供更可预测的穿刺深度和符合人体工学的设计。多层次深度调节和静音机制等创新技术正在提高采血针的普及率,尤其是在老年人和神经功能障碍患者中,这限制了压力/接触式采血针的市场成长。
机会
向家庭医疗保健监测的转变带来了充满希望的机会。由于人们对经济便利的血糖监测的需求日益增长,自我血糖监测也越来越普遍。无需启动依钮的接触式采血针非常适合未经训练的用户,包括老年人和儿童患者。例如,2023 年的一项研究报告称,印度有 35% 的患者在家中使用血糖仪进行自我血糖监测,这表明家用诊断工具的需求正在增长。
挑战
在中低收入国家,血糖监测工具的普及率低,且价格昂贵,这限制了市场扩张。在孟加拉等医疗基础设施欠发达的国家,公共医疗支出仅占 GDP 的 2.34%,限制了其普及。此外,缺乏相关知识以及製造商不愿进入这些地区也是市场成长面临的挑战。
市场趋势
超细针尖技术和人体工学设计的融合是主要趋势。采用 21G 至 30G 超细针头和弹簧式装置的采血针可实现几乎无痛的采血。使用可生物降解组件的可持续设计正在兴起,以减少对环境的影响。同时,监管标准仍建议在临床环境中使用设计安全、锋利的器械。
依切口类型:针式采血针因其安全性高、疼痛轻、易于使用而占主导地位。刀片式采血针的需求也在成长,尤其是在新生儿和多项检测应用。
依年龄层:虽然由于糖化血红素 (HbA1c)、胆固醇和凝血功能检测的需求,采血针在成人的应用最为普遍,但 1 型糖尿病儿童的使用也在增加。
依应用:由于自我管理趋势,血糖监测引领市场,其次是血红素检测,此项检测正在快速成长。这主要受糖化血红蛋白 (HbA1c) 检测需求的驱动。
依规格:由于需要尽可能减少伤口和采集少量血液,28G 以上规格的采血针占主导地位。 22G 及以下规格的采血针则用于需要较大样本量的临床实验室。
依分销管道:预计到 2025 年,医院药房将占主导地位,但由于便利性和电子商务的日益普及,预计在线药房的复合年增长率 (CAGR) 将最高。
The global pressure/contact-activated safety lancet market was valued at USD 456.23 million in 2025 and is projected to grow to USD 502.67 million in 2026, reaching USD 1,164.18 million by 2034, representing a CAGR of 11.07% during the forecast period. North America dominated the market in 2025 with a 42.37% share, equivalent to USD 193.32 million, driven by strong demand for advanced devices and significant reimbursement for chronic disease monitoring products.
Pressure/contact-activated safety lancets are single-use, disposable devices used for capillary blood sampling in diabetes management and diagnostic applications. They feature automatic retraction and are activated when slight pressure is applied on the fingertip. Their ease of use, limited pain, and minimal blood loss are key factors driving adoption in hospitals, clinics, and home healthcare settings.
Market Dynamics
Drivers
The rising prevalence of diabetes globally is a major market driver. Frequent blood glucose monitoring is required for effective diabetes management, fueling the demand for safety lancets. Pressure-activated lancets offer consistent penetration depth, reduced risk of needlestick injuries, and convenience for self-monitoring at home. According to the International Diabetes Federation (July 2025), 589 million adults lived with diabetes globally in 2024, a number projected to reach 853 million by 2050, highlighting the sustained need for lancets.
Increasing awareness about safe diabetes care and adoption of minimally invasive technologies further drives market growth across hospitals, clinics, and home care.
Restraints
The market faces competition from button-activated lancets, which provide more predictable depth penetration and ergonomic designs. Innovations such as multi-depth adjustment and quieter mechanisms have increased their adoption, particularly among elderly or neuropathic patients, limiting the market growth of pressure/contact-activated devices.
Opportunities
The shift toward home healthcare monitoring offers lucrative opportunities. Self-monitoring of blood glucose is increasing due to the need for cost-effective and convenient care. Contact-activated lancets, eliminating the need for activation buttons, are ideal for untrained users, including elderly and pediatric patients. For instance, a 2023 study reported that 35% of patients in India self-monitored blood glucose at home using glucometers, demonstrating rising demand for at-home diagnostic tools.
Challenges
Limited accessibility and affordability in low- and middle-income countries restrict market expansion. Countries with less-developed healthcare infrastructure, such as Bangladesh, spend as little as 2.34% of GDP on public healthcare, limiting adoption. Awareness gaps and hesitation among manufacturers to enter these regions also pose growth challenges.
Market Trends
Integration of ultra-fine gauge technology and ergonomic designs is a key trend. Lancets with 21G-30G ultra-thin needles and spring-loaded mechanisms provide nearly painless sampling. Sustainability-focused designs using biodegradable components are emerging to reduce environmental impact, while regulatory standards continue to favor safety-engineered sharps in clinical settings.
By Incision Type: Needle lancets dominate due to safety, less pain, and ease of use. Blade lancets are also growing, especially for neonatal and multi-test applications.
By Age Group: Adults dominate adoption, driven by HbA1c, cholesterol, and coagulation testing, while pediatric usage is increasing among Type 1 diabetes patients.
By Application: Blood glucose monitoring leads the market, driven by self-monitoring trends, followed by hemoglobin testing, which is growing rapidly due to HBA1C testing demand.
By Gauge Size: Lancets above 28G dominate for minimal trauma and small blood volume needs. 22G and below are used in clinical labs requiring higher sample yields.
By Distribution Channel: Hospital pharmacies lead in 2025, while online pharmacies are expected to register the highest CAGR due to convenience and growing e-commerce penetration.
Competitive Landscape
The market is moderately consolidated. Leading players include BD, HTL-STREFA, Cardinal Health, Medline Industries, Braun SE, Aeras Medical, and Owen Mumford. Strategic initiatives such as new product launches, geographic expansion, and promotional activities at conferences strengthen their market position.
Key Developments:
Conclusion
The global pressure/contact-activated safety lancet market, valued at USD 456.23 million in 2025, is projected to grow to USD 502.67 million in 2026 and reach USD 1,164.18 million by 2034 at a CAGR of 11.07%. Growth is driven by rising diabetes prevalence, demand for self-monitoring, adoption of ultra-fine gauge and ergonomic designs, and expanding home healthcare trends. While competition from button-activated lancets and limited accessibility in low-income regions pose challenges, technological innovation, increasing home diagnostics, and favorable reimbursement policies are expected to sustain market expansion through 2034.
Segmentation By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Region
By Incision Type * Needle
By Age Group * Adult
By Application * Blood Glucose Monitoring
By Gauge Size * 22G and Below
By Distribution Channel * Hospital Pharmacies
By Region * North America (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Country)